PRCT - Company ID 0001588978
The table below shows PROCEPT BioRobotics Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$38.13M | -$16.98M | -$32.29M | -$35.93M | -$18.23M | -$15.20M |
| Capital expenditure | $2.91M | $1.84M | $1.95M | $5.34M | $55.00K | $39.00K |
| Investing cash flow | -$2.91M | -$1.84M | -$1.95M | -$5.34M | -$55.00K | -$39.00K |
| Dividends paid | - | - | - |
PROCEPT BioRobotics Corp reported operating cash flow of -$48.98M for fiscal year 2025. That is up 50.6% from -$99.21M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$48.34M (FY 2020) to -$48.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $222.00K | $1.30M | $2.59M | $380.00K | $1.29M | $1.23M |